Serum amyloid A: An acute phase apolipoprotein and precursor of AA amyloid

Bailliere's Clinical Rheumatology

Volumn 8, Issue 3, 1994, Pages 553-573

  Marhaug, Gudmund ^a   Dowton, S Bruce ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMINO ACID; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN; CORTICOSTEROID; CYTOKINE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; SERUM AMYLOID A; TUMOR NECROSIS FACTOR;

AMINO ACID SEQUENCE; CHROMOSOME 11P; CHROMOSOME 7; CROSS REACTION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; RAT; REVIEW;

ACUTE-PHASE PROTEINS; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PROTEIN AA; ANIMAL; APOLIPOPROTEINS; BASE SEQUENCE; HUMAN; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY;

EID: 0028145489     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(05)80115-3     Document Type: Article

References (144)

1. SAA suppression of immune response in vitro: Evidence for an effect on T cell-macrophage interaction
2. Acute-phase high density lipoprotein in the rat does not contain serum amyloid A protein
3. Heterogeneity of human serum amyloid A proteins
4. 2-terminal analysis of four of the plymorphic forms of human serum amyloid A proteins
5. Degradation of serum amyloid A by isolated perfused rat liver
6. Time course of serum amyloid A response in myocardial infarction
7. Human serum amyloid A protein. Complete amino acid sequence of a new variant
8. Amyloid protein SAA is associated with high density lipoprotein from human serum
9. Expression of the third member of the serum amyloid A gene family in mouse adipocytes
10. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells
11. IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells
12. Differential induction of the serum amyloid A gene family in response to an inflammatory agent and to amyloid-enhancing factor
13. A rapid enzyme-linked immunosorbent assay for serum amyloid A using sequence-specific antibodies
14. Clinical relevance of serum amyloid A protein monitoring in urinary tract infections
15. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease
16. Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation
17. Estrogen-dependent activation of the avian very low density apolipoprotein II and vitellogenin genes
18. Serum amyloid A-containing human high density lipoprotein 3
19. IL-1 receptor antagonist affects the plasma protein response of Hep 3B cells to conditioned medium from lipopolysaccharide-stimulated monocytes
20. Identification of a novel serum amyloid A protein in BALB/c mice
21. Mouse serum amyloid A protein. Complete amino acid sequence and mRNA analysis of a new isoform
22. Interleukin-1 and the pathogenesis of the acute phase response
23. Regulation of serum amyloid A gene expression in syrian hamsters by cytokines
24. Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual
25. Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor κB-like transcription factor
26. Primary structure of duck amyloid protein A The form deposited in tissues may be identical to its serum precursor
27. Detection of human serum amyloid A protein in very low density and high density lipoproteins of patients after acute myocardial infarction
28. Serum amyloid A protein in mink during endotoxin induced inflammation and amyloidogenesis.
29. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells
30. apo-SAA1/apo-SAA2 isotype ratios during casein- and amyloid-enhancing-factor induced secondary amyloidosis in A/J and C57BL/6J mice
31. Amyloid deposits and amyloidosis—the β-fibrilloses I and II
32. Amyloid deposits and amyloidosis—the β-fibrilloses I and II
33. The plasma lecithins: cholesterol acyltransferase reaction
34. Transcriptional regulation of genes encoding the acute-phase proteins CRP, SAA and C3
35. Hepatic catabolism of serum amyloid A during an acute phase response and chronic inflammation
36. Amyloid resistance in the CE/J mouse
37. Polymorphism of tissue and serum amyloid A (AA and SAA) proteins in the mouse
38. SAA isoform patterns in patients with and without AA-amyloidosis
39. Apo-SAA1/apo-SAA2 isotype ratios during casein—an amyloid-enhancing-factor-induced secondary amyloidosis in A/J and C57BL/6J mice
40. Secretion of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture
41. Changes in high-density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions
42. 2-terminal sequence identity with only one of two serum amyloid proteins (apoSAA) gene products
43. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils
44. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo
45. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL)
46. Serum amyloid A (SAA), a protein without a function: Some suggestions with reference to cholesterol metabolism
47. DMA sequence evidence for polymorphic forms of human serum amyloid A (SAA)
48. Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms
49. Sequences analysis of a third human SAA gene
50. Nonexpression of the serum amyloid A three (SAA3) gene
51. The phenomenon of the acute phase response. In C-reactive protein and the plasma protein response to tissue injury
52. Serum markers of immune activation and liver allograft rejection
53. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes
54. 2–82—on platelet aggregation
55. IMMUNOLOGIC STUDIES OF THE MAJOR NONIMMUNOGLOBULIN PROTEIN OF AMYLOID: I. IDENTIFICATION AND PARTIAL CHARACTERIZATION OF A RELATED SERUM COMPONENT
56. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NFκB-like transcription factors
57. The primary structure of serum amyloid A protein in the rabbit: Comparison with serum amyloid A proteins in other species
58. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein
59. Transcriptional regulation of serum amyloid A gene expression
60. Structure of the murine serum amyloid A gene family
61. Three assays for the characterization and quantitation of human serum amyloid A
62. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA)
63. Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis
64. Serum amyloid A protein in acute myocardial infarction
65. Mink serum amyloid A protein. Expression and primary structure based on cDNA sequences
66. IL-6 modulates the synthesis of a specific set of acute phase proteins in vivo
67. Comparative study of serum amyloid-related protein and β-2-microglobulin as markers of renal allograft rejection
68. Serum amyloid A protein, apolipoprotein A-1, and apolipoprotein B during the course of acute myocardial infarction
69. Amyloid A gene family expression in different mouse tissues
70. Rat tissues express serum amyloid A protein-related mRNAs
71. Amyloidogenesis. One serum amyloid A isotype is selectively removed from circulation
72. Serum amyloid A in the mouse. Sites of uptake and mRNA expression
73. Mouse SAA3 detection in mouse tissues with specific antibody
74. 3 is a high density apolipoprotein and is secreted by macrophages
75. Expression of human apoSAA gene in cells of atherosclerotic lesions
76. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and in neutralized with specific antiserum
77. The acute phase reactant serum amyloid A (SAA3) is a noval substrate for degradation by the metalloproteinases collagenase and stromelysin
78. Serum amyloid A protein in acute viral infections
79. Serum amyloid A: An extremely sensitive marker for intensity of tissue damage in trauma patients and indicator of acute phase response in various diseases
80. Recombinant human tumour necrosis factor-alpha (rhTNF-alpha) and rhTNF-alpha analogue enhance amyloid deposition in the Syrian hamster
81. Suppression of IL-2 induced SAA gene expression in mice by the administration of an IL-1 receptor antagonist
82. Quantitative dot-blot enzyme immunoassay for serum amyloid A protein
83. Glucocorticoids enhance stability of human growth hormone mRNA
84. Alteration of high density lipoprotein subfraction distribution with induction of serum amyloid A protein (SAA) in non-human primate
85. 1) from human high-density lipoprotein
86. Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression
87. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1
88. Serum amyloid A isoforms in inflammation
89. Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6
90. Inhibition of SAA synthesis
91. Regulation of amyloid A gene expression in cultured cells
92. Molecular and cellular biology of serum amyloid A
93. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes
94. The complete amino acid sequence of bovine serum amyloid protein A (SAA) and of subspecies of the tissue-deposited amyloid fibril protein A
95. Rabbit serum amyloid A: Expression and primary structure deduced from cDNA sequences
96. Differential expression of rabbit serum amyloid A genes in response to various inflammatory agents
97. Expression of serum amyloid A genes in mink during induction of inflammation and amyloidosis
98. Molecular cloning of human genes for serum amyloid A
99. Highly polymorphic domains of the humans serum amyloid A (SAA) gene GSAA1
100. The human serum amyloid A locus SAA4 is a pseudogene
101. Variation in apolipoproteins serum amyloid A, A-I, A-II, and C-III in serverely head-injured patients
102. 2 in mice
103. 1-acid glycoprotein RNA during inflammation
104. Intralysosomal formation of amyloid fibrils
105. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation
106. Specific deposition of serum amyloid A protein 2 in the mouse
107. Human serum amyloid A (SAA): Biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA
108. Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA)
109. 3 subtype if selectively deposited as AA fibrils
110. Degradation of protein SAA to an AA-like fragment by enzymes of monocytic origin
111. The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis
112. The covalent structure of amyloid-related serum protein SAA from two patients with inflammatory disease
113. The primary structure of equine serum amyloid A (SAA) protein
114. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednislone
115. A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2)
116. Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly (A) tail shortening and translational efficiency
117. Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis
118. Influence of serum amyloid A on cholesterol esterification in human plasma
119. Identification of three isoform patterns of human serum amyloid A protein
120. Human serum amyloid A protein: The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci
121. Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis
122. Evolutionary aspects of protein SAA
123. The revised amino acid sequence of serum amyloid A (SAA) protein in mink
124. The Primary Structure of Serum Amyloid A Protein in the Sheep: Comparison with Serum Amyloid A in Other Species
125. The primary structure of rabbit serum amyloid A protein isolated from acute phase serum
126. Molecular cloning, nucleotide sequence heterozygosity and regulation of rabbit serum amyloid A cDNA
127. Genes for serum amyloid A proteins map to chromosome 7 in the mouse
128. Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites
129. ApoSAA expression by human monocyte cell line, THP-1
130. Serum amyloid A protein in plasma: characteristics of acute phase HDL
131. Amyloidosis
132. The primary structure of amyloid fibril protein AA in endotoxin-induced amyloidosis of the mink
133. Expression and sequence analyses of serum amyloid A in the syrian hamster
134. The N-terminal segment of protein AA determines its fibrillogenic property
135. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein
136. Automated immunoassay for SAA
137. Structure of human serum amyloid A gene and modulation of its expression in transfected L cells
138. The human serum amyloid A genes and their regulation by inflammatory cytokines
139. Sandwich enzyme immunoassay for serum amyloid A protein (SAA)
140. Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences.
141. Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction
142. Structural diversity of murine serum amyloid A genes: Evolutionary implications
143. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes
144. Serum amyloid A, an acute phase protein, inhibits platelet activation